TABLE 1.

P values for the difference in model predictions among Canadian provinces for the linear mixed model describing provincial differences in macrolide and lincosamide prescriptions per 1000 inhabitant-days, 1995 to 2010

	BC	MB	NB	NF	NS	ON	PE	QC	SK
AB	0.010	ns	ns	ns	ns	ns	ns	0.011	ns
BC	–	ns	0.007	<0.001	0.036	0.009	<0.001	ns	0.006
MB	–	–	ns	0.019	ns	ns	ns	ns	ns
NB	–	–	–	ns	ns	ns	ns	0.007	ns
NF	–	–	–	–	0.030	ns	ns	<0.001	ns
NS	–	–	–	–	–	ns	ns	0.036	ns
ON	–	–	–	–	–	–	ns	0.009	ns
PE	–	–	–	–	–	–	–	<0.001	ns
QC	–	–	–	–	–	–	–	–	0.006

A significant P value indicates that a significant difference in prescribing exists between the provinces. AB Alberta; BC British Columbia; MB Manitoba; NF Newfoundland and Labrador; ns No significant difference between the provincial estimates; NS Nova Scotia; ON Ontario; PE Prince Edward Island; QC Quebec; SK Saskatchewan